Compare CleanSpark Inc (CLSK) vs Davita Inc (DVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CleanSpark Inc vs Davita Inc — how do they compare? CleanSpark Inc trades at $11.78 (market cap $2.98B), while Davita Inc trades at $178.34 (market cap $11.72B). The key difference: Davita Inc is far larger — about 3.9× CleanSpark Inc's market cap, and Davita Inc is trading nearer its 52-week high, CleanSpark Inc nearer its low. Which is the better fit depends on your goals.
| CLSK | DVA | |
|---|---|---|
Market Cap | $2.98B | $11.72B |
Sector | Technology | Health |
52-Week High | $23.20 | $240.96 |
52-Week Low | $8.18 | $103.87 |
Enterprise Value | $3.97B | $24.44B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CleanSpark (CLSK) trades at $12.30, down 3.53% amid a bearish technical outlook despite unanimous analyst buy ratings. The stock faces fundamental challenges with four consecutive quarterly earnings misses and negative profitability margins (-146.9% net income margin). Recent developments include a strategic pivot toward AI data centers, highlighted by a 20-year, $6.6 billion lease agreement in Sandersville, Georgia, which aims to diversify revenue streams beyond Bitcoin mining.
The stock presents a high-risk, high-reward opportunity with analysts projecting 94% upside to a $23.89 consensus target. Key risks include persistent earnings underperformance, negative cash flow from operations, and execution challenges in the AI infrastructure transition. Investors must weigh the long-term potential of the data center pivot against near-term financial volatility and dilution concerns.
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CleanSpark Inc
CleanSpark is a leading Bitcoin mining company that operates high-density data centers. It focuses on using sustainable energy to power its mining fleet and provides digital infrastructure for the blockchain ecosystem.
Read more on CLSK →About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →
